The MEK inhibitor binimetinib resulted in improved progression - free survival and response rates vs
dacarbazine in patients with NRAS - mutated metastatic melanoma.
Not exact matches
In the control arm, dacarbazine was not used in compliance with the approval, however: Instead of administration in combination with another drug (doxorubicin), dacarbazine was used as monotherapy, and a different dosage was used in the beginning of the treatmen
In the control arm,
dacarbazine was not used
in compliance with the approval, however: Instead of administration in combination with another drug (doxorubicin), dacarbazine was used as monotherapy, and a different dosage was used in the beginning of the treatmen
in compliance with the approval, however: Instead of administration
in combination with another drug (doxorubicin), dacarbazine was used as monotherapy, and a different dosage was used in the beginning of the treatmen
in combination with another drug (doxorubicin),
dacarbazine was used as monotherapy, and a different dosage was used
in the beginning of the treatmen
in the beginning of the treatment.
In its dossier, the drug manufacturer used one study of direct comparison that tested eribulin against
dacarbazine.
Plerixafor
in combination with the chemotherapeutic agent
dacarbazine significantly suppressed the metastatic phenotype of melanoma compared to
dacarbazine alone [40].
Dacarbazine - based chemotherapy as first - line treatment
in noncutaneous metastatic melanoma: multicenter, retrospective analysis
in Asia.
[61,62] Small retrospective studies of biochemotherapy (cisplatin, vinblastine,
dacarbazine, interferon alfa - 2b, and IL - 2) also demonstrated activity that was similar
in cutaneous and mucosal melanomas.
Although
dacarbazine has been part of the standard of care for metastatic melanoma for more than 30 years, it has never been shown to increase overall survival
in this patient population.
Mature results of a phase III randomized trial of bacillus Calmette - Guerin (BCG) versus observation and BCG plus
dacarbazine versus BCG
in the adjuvant therapy of American Joint Committee on Cancer stage I - III melanoma (E1673).